Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreoni

Showing results (1101-1110 of 1,171) with videos related to

Pageof 118
Sort By:
Emerging Microbes & Infections|June 8, 2023
Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategiesLorenzo Piermatteo, Stefano D'Anna, Ada Bertoli, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimenD Armenia, D Di Carlo, A Calcagno, et al.
Journal of Viral Hepatitis|August 17, 2018
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosisChiara Masetti, Raffaella Lionetti, Marinella Lupo, et al.
Biomedicines|October 23, 2021
HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV ReactivationLorenzo Piermatteo, Mohammad Alkhatib, Stefano D'Anna, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2012
Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infectionEmanuela Greco, Gianluca Quintiliani, Marilina B Santucci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2015
A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinomaG Rosati, G Ambrosini, S Barni, et al.
The Journal of Antimicrobial Chemotherapy|April 12, 2006
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005)G Carosi, C Torti, M Andreoni, et al.
Antiviral Research|November 17, 2011
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detectionValentina Svicher, Valeria Cento, Martina Bernassola, et al.
Blood|June 11, 1999
Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcomaP Monini, S Colombini, M Stürzl, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2020
Matched-Pair Analysis of Transplant from Haploidentical, Unmanipulated Bone Marrow Donor versus HLA Identical Sibling for Patients with Hematologic MalignanciesWilliam Arcese, Raffaella Cerretti, Loredana Sarmati, et al.
Pageof 118

Showing results (1101-1110 of 1,171) with videos related to

Sort By:
Pageof 118
Emerging Microbes & Infections|June 8, 2023
Unexpected rise in the circulation of complex HBV variants enriched of HBsAg vaccine-escape mutations in HBV genotype-D: potential impact on HBsAg detection/quantification and vaccination strategiesLorenzo Piermatteo, Stefano D'Anna, Ada Bertoli, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2016
Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimenD Armenia, D Di Carlo, A Calcagno, et al.
Journal of Viral Hepatitis|August 17, 2018
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosisChiara Masetti, Raffaella Lionetti, Marinella Lupo, et al.
Biomedicines|October 23, 2021
HBeAg Levels Vary across the Different Stages of HBV Infection According to the Extent of Immunological Pressure and Are Associated with Therapeutic Outcome in the Setting of Immunosuppression-Driven HBV ReactivationLorenzo Piermatteo, Mohammad Alkhatib, Stefano D'Anna, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2012
Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infectionEmanuela Greco, Gianluca Quintiliani, Marilina B Santucci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 19, 2015
A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinomaG Rosati, G Ambrosini, S Barni, et al.
The Journal of Antimicrobial Chemotherapy|April 12, 2006
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005)G Carosi, C Torti, M Andreoni, et al.
Antiviral Research|November 17, 2011
Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detectionValentina Svicher, Valeria Cento, Martina Bernassola, et al.
Blood|June 11, 1999
Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcomaP Monini, S Colombini, M Stürzl, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2020
Matched-Pair Analysis of Transplant from Haploidentical, Unmanipulated Bone Marrow Donor versus HLA Identical Sibling for Patients with Hematologic MalignanciesWilliam Arcese, Raffaella Cerretti, Loredana Sarmati, et al.
Pageof 118